Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Spectral Medical Inc > Morningstar report on TD Waterhouse
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(24)
•••
Post by money4golfon Sep 29, 2024 7:49pm
781 Views
Post# 36246294

Morningstar report on TD Waterhouse

Morningstar report on TD WaterhouseI like reading this instead of watching TD and Scotia seemingly bring the price down....
This is on the TD Waterhouse website last report.
 
Quantitative Equity Research Report | Release: 27 Sep 2024, 02:58 UTC | Reporting Currency: CAD | Trading Currency: CAD | Exchange: TORONTO STOCK EXCHANGE
Spectral Medical Inc EDT QQQ Q 26 Sep 2024 22:40, UTC
Fair Value $1.62
Valuation as of 26 Sep 2024
Morningstar affirms a 3-star quantitative rating for
Spectral Medical. We calculate this outcome using
the company's underlying model-driven valuation
and uncertainty scores.
The stock's last closing price was 0.62, a discount
of 58.76% to its Quantitative Fair Value estimate of
$1.50.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities